108 results
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... with caution in pulmonary ... disease or CHF) ... disease or CHF) ... #management #cardiology
Heart Failure with Preserved Ejection Fraction: Management Principles

General Therapeutic Principles:
Reduce the congestive state 
 - Caution
Ejection Fraction: Management ... sinus rhythm in atrial ... hypertension, pulmonary ... #Cardiology #HFpEF ... #Treatment #HeartFailure
Multifocal Atrial Tachycardia (MAT)
• At least 3 different P wave morphologies: 
• Rate 100-180
• Irregular 
Etiology
Multifocal Atrial ... • Hypoxia • Pulmonary ... • Oxygen • Treatment ... #Multifocal #Atrial ... Tachycardia #MAT #Cardiology
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
Guideline for the Management ... #HeartFailure #Management ... #CHF #guideline ... #treatment #algorithm ... #sCHF
Atrial Fibrillation Overview

Symptoms:
Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

1. Why?
Cardiac:
• Valvular heart disease
•
Atrial Fibrillation ... Decompensated HF ... Noncardiac: • Pulmonary ... #Fibrillation #Cardiology ... #Management #Algorithm
Diagnostic algorithm for a child or adolescent with suspected pulmonary hypertension. CHD, congenital heart disease; CPET,
CHD, congenital ... arterial hypertension ... arterial hypertension ... ; PCH, pulmonary ... liver function test
Atrial Flutter - Summary Sheet

 • Electrophysiology - Typical and Atypical Flutter
 • Treatment
Atrial Flutter - ... Atypical Flutter • Treatment ... Summary #diagnosis #management ... #cardiology
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
prescribing and management ... in Pulmonary Arterial ... #prescribing #Pulmonary ... #PAH #Management ... #Algorithm #treatment
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
development of HF ... inhibitor; AF, atrial ... #CHF #Congestive ... ACCAHA #Algorithm #Management ... #Cardiology
Pulmonary Embolism Therapies

Aligning therapeutic options with the severity of pulmonary embolism. Yellow boxes represent therapies requiring
Pulmonary Embolism ... the severity of pulmonary ... prospective clinical trials ... Therapies #Severity #Management ... #Treatment